Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better.

From the week of March 09th, we are planning to work on 15 projects, including:

Reimbursement

1. Delivering reimbursement analysis for novel technology in organ transplantation in France
2. Delivering a market access strategy for invasive diagnostic imaging technology in the cardiovascular area in England, France, and Germany
3. Delivering market access strategy for minimally invasive technology in the urology area in eight European countries
4. Working on reimbursement analysis for extracorporeal treatment in ten European countries
5. Working on reimbursement analysis for an in-vitro diagnostic test in the hematology area in England, France, Germany, and Italy
6. Working on reimbursement analysis for minimally invasive technology in the neurology area in Denmark, Finland, Norway, and Sweden
7. Working on reimbursement analysis for an in-vitro diagnostic test in the oncology area in France, Germany, Italy, and Spain
8. Initiating work on reimbursement analysis for minimally invasive technology in vascular surgery in Denmark, England, France, Germany, Italy, Sweden, and Switzerland
9. Initiating work on reimbursement analysis for minimally invasive technologies in oncology and vascular surgery in England, Germany, and the Netherlands

HEOR

1. Working on the development of a health economic model for in-vitro diagnostic tests in neurology disease areas in England, France, Germany, Italy, and Spain 
2. Working on the adaptation of a health economic model for an imaging diagnostic system in different European and Middle Eastern countries
3. Working on the validation of a health economic model in the cardiology area
4. Working on a systematic literature review and meta-analysis for an in vitro diagnostic test
5. Initiating work on the development of a health economic model for technology in the cardiovascular area in England
6. Initiating work on evidence gap analysis for minimally invasive technology in vascular surgery 

Let us know if you need any market access or HEOR support for your medical technology in Europe